Study #2022-0216
Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma
MD Anderson Study Status
Enrolling
Treatment Agent
Pomalidomide
Description
This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Skin Kaposi Sarcoma
Study phase:
Phase II
Physician name:
Elizabeth Chiao
Department:
Epidemiology
For general questions about clinical trials:
1-855-404-4637
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.